This inventor holds 4 USPTO granted patents. Top assignees: Myriad Genetics, Inc., University of Utah Research Foundation, The United States of America as Represented by the Department of Health. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 123 
4 out of 1,688 
2 out of 1,217 
Years Active: 1998-2000
Title: Yoshio Miki: Pioneer in Breast and Ovarian Cancer Research
Introduction
Yoshio Miki is an esteemed inventor based in Salt Lake City, UT, renowned for his significant contributions to the field of human genetics, particularly in the study of breast and ovarian cancer. With a portfolio that includes four patents, Miki's work has provided critical insights into cancer susceptibility and innovative therapeutic approaches.
Latest Patents
Yoshio Miki's latest patents focus primarily on the discovery and utilization of the BRCA1 gene, which is integral in understanding predisposition to breast and ovarian cancer. The patents describe methods and materials for isolating and detecting germline mutations in the BRCA1 gene that may increase cancer susceptibility. Furthermore, Miki's inventions encompass the analysis of somatic mutations within the BRCA1 gene, with applications in diagnosing and prognosticating breast and ovarian cancer, as well as other human cancers. His inventions also provide pathways for novel cancer therapies, including gene therapy, protein replacement therapy, and the development of protein mimetics. Additionally, the patents include methodologies for drug screening targeting these genetic mutations, offering hope for more targeted cancer treatments.
Career Highlights
Yoshio Miki has held notable positions at the University of Utah Research Foundation and Myriad Genetics, Inc. His expertise in genetic research and patent development has established him as a leading figure in the advancement of cancer research.
Collaborations
Throughout his career, Miki has collaborated with several prominent researchers, including Mark H. Skolnick and David E. Goldgar. These collaborations have enhanced the depth of research and innovation within the domain of genetics and oncology, significantly influencing cancer risk assessment and management.
Conclusion
Yoshio Miki's groundbreaking work in the field of human genetics and cancer susceptibility has made substantial impacts on both scientific understanding and patient care. Through his innovative patents and collaborations, he continues to contribute to the fight against breast and ovarian cancer, establishing a legacy of excellence in medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile